Hip fractures
Conditions
Interventions
Neurolytic (modified) PEricapsular Nerve Group block / hip denervation with ultrasound guidance
Sponsors
Radboudumc
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: "- Mediale collumfractuur of pertrochantere heupfractuur - Leeftijd > 18 jaar - Besloten tot conservatieve behandeling na multidisciplinair overleg of op verzoek patiënt/vertegenwoordiger - Informed consent verkregen"
Exclusion criteria
Exclusion criteria: "- Subtrochantere of meer distale femurfracturen - Periprothetische fractuur - Acetabelumfractuur - Dubbelzijdige fractuur - Geen informed consent verkregen"
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life | — |
Secondary
| Measure | Time frame |
|---|---|
| - Mobility (direct, after 1 and 4 weeks and 3 months - Mortality (30 days, in hospital, 1 year) - NRS before and directly after, after 1 and 4 weeks or PACSLAC-D before vs directly after, after 1 and 4 weeks - opioid consumption - treatment satisfaction of patient (or proxy) and caregivers (1-10) - quality of dying (QODD) - time to death (in days to months) - Complications | — |
Contacts
Public ContactRachel Smits
Radboudumc
Outcome results
None listed